D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$701M |
| 2 |
Booking.com
BKNG
|
+$503M |
| 3 |
Alibaba
BABA
|
+$443M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$389M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$267M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.03B |
| 2 |
Amazon
AMZN
|
+$463M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$436M |
| 4 |
Salesforce
CRM
|
+$387M |
| 5 |
Moderna
MRNA
|
+$354M |
Sector Composition
| 1 | Technology | 20.28% |
| 2 | Consumer Discretionary | 13.97% |
| 3 | Healthcare | 10.06% |
| 4 | Financials | 9.79% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
ESSA Pharma
EPIX
$9.6M
| $2.53M | ﹤0.01% |
+315,731
| New | +$2.53M |
|
|
GGGV
1802
DELISTED
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
| $2.52M | ﹤0.01% |
+252,026
| New | +$2.52M |
|
1803
Team
TISI
$81.8M
| $2.51M | ﹤0.01% |
83,503
+46,463
| +125% | +$1.4M |
|
1804
O-I Glass
OI
$1.99B
| $2.51M | ﹤0.01% |
176,098
-42,470
| -19% | -$606K |
|
1805
Openlane
KAR
$3.07B
| $2.51M | ﹤0.01% |
153,172
-151,652
| -50% | -$2.49M |
|
1806
Apple Hospitality REIT
APLE
$2.98B
| $2.51M | ﹤0.01% |
159,424
-110,864
| -41% | -$1.74M |
|
1807
Angi Inc
ANGI
$760M
| $2.5M | ﹤0.01% |
20,287
-42,885
| -68% | -$5.29M |
|
1808
AngioDynamics
ANGO
$433M
| $2.5M | ﹤0.01% |
96,397
-24,324
| -20% | -$631K |
|
1809
ARS Pharmaceuticals
SPRY
$991M
| $2.5M | ﹤0.01% |
250,580
+40,453
| +19% | +$404K |
|
|
STRE
1810
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
| $2.5M | ﹤0.01% |
257,300
+173,967
| +209% | +$1.69M |
|
1811
Orchestra BioMed
OBIO
$139M
| $2.5M | ﹤0.01% |
252,518
+222,717
| +747% | +$2.2M |
|
1812
Ambev
ABEV
$35.9B
| $2.49M | ﹤0.01% |
903,664
-2,016,627
| -69% | -$5.57M |
|
1813
Apellis Pharmaceuticals
APLS
$3.14B
| $2.49M | ﹤0.01% |
75,522
-169,507
| -69% | -$5.59M |
|
|
MSPR
1814
MSP Recovery, Inc. Class A Common Stock
MSPR
$1.78M
| $2.48M | ﹤0.01% |
57
-11
| -16% | -$478K |
|
1815
Clean Harbors
CLH
$12.7B
| $2.47M | ﹤0.01% |
+23,809
| New | +$2.47M |
|
1816
Dorman Products
DORM
$4.93B
| $2.46M | ﹤0.01% |
26,024
+10,437
| +67% | +$988K |
|
1817
Lindsay Corp
LNN
$1.52B
| $2.46M | ﹤0.01% |
16,229
-67
| -0.4% | -$10.2K |
|
|
LDHA
1818
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
| $2.45M | ﹤0.01% |
250,500
+217,167
| +652% | +$2.12M |
|
1819
Ovid Therapeutics
OVID
$89.6M
| $2.45M | ﹤0.01% |
728,930
-16,985
| -2% | -$57.1K |
|
|
NKGN
1820
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $2.45M | ﹤0.01% |
+252,656
| New | +$2.45M |
|
|
XPOA
1821
DELISTED
DPCM Capital, Inc.
XPOA
| $2.45M | ﹤0.01% |
+250,335
| New | +$2.45M |
|
|
AVID
1822
DELISTED
Avid Technology Inc
AVID
| $2.44M | ﹤0.01% |
84,344
+69,163
| +456% | +$2M |
|
|
WPCA
1823
DELISTED
Warburg Pincus Capital Corporation I-A
WPCA
| $2.44M | ﹤0.01% |
248,133
+164,800
| +198% | +$1.62M |
|
|
LJPC
1824
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.44M | ﹤0.01% |
610,654
-36,874
| -6% | -$147K |
|
|
PAFOU
1825
DELISTED
Pacifico Acquisition Corp. Units
PAFOU
| $2.44M | ﹤0.01% |
+240,000
| New | +$2.44M |
|